Abstract: A series of hepatitis C virus (HCV) inhibitors and compositions and applications thereof in the preparation of drugs for treating chronic HCV infection. Especially, a series of compounds that are used as NS5A inhibitors, and compositions and uses thereof in the preparations of drugs.
Type:
Grant
Filed:
February 6, 2015
Date of Patent:
December 25, 2018
Assignees:
CHANGZHOU YINSHENG PHARMACEUTICAL CO., LTD., SICHUAN UNIVERSITY
Inventors:
Yang Zhang, Chunli Shen, Jian Li, Shuhui Chen, Guoping Hu, Yuquan Wei, Luoting Yu, Xin Tao
Abstract: Provided is a benzofuran analog having a structure represented by formula (I) and used as an NS4B inhibitor, or a pharmaceutically acceptable salt of the benzofuran analog. The benzofuran analog has anti-hepatitis C virus activity.
Type:
Grant
Filed:
September 23, 2015
Date of Patent:
October 16, 2018
Assignees:
CHANGZHOU YINSHENG PHARMACEUTICAL CO., LTD., SICHUAN UNIVERSITY
Inventors:
Yang Zhang, Zhifei Fu, Jianfei Wang, Jian Li, Shuhui Chen, Yuquan Wei, Luoting Yu, Xin Tao